Cargando…

Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening

(1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero-Aroca, Pedro, Baget-Bernaldiz, Marc, Sagarra, Ramon, Hervás, Esther, Blasco, Reyes, Molina, Julia, Moreno, Empar F., Garcia-Curto, Eugeni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737650/
https://www.ncbi.nlm.nih.gov/pubmed/36498696
http://dx.doi.org/10.3390/jcm11237121
_version_ 1784847343610232832
author Romero-Aroca, Pedro
Baget-Bernaldiz, Marc
Sagarra, Ramon
Hervás, Esther
Blasco, Reyes
Molina, Julia
Moreno, Empar F.
Garcia-Curto, Eugeni
author_facet Romero-Aroca, Pedro
Baget-Bernaldiz, Marc
Sagarra, Ramon
Hervás, Esther
Blasco, Reyes
Molina, Julia
Moreno, Empar F.
Garcia-Curto, Eugeni
author_sort Romero-Aroca, Pedro
collection PubMed
description (1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored.
format Online
Article
Text
id pubmed-9737650
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97376502022-12-11 Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening Romero-Aroca, Pedro Baget-Bernaldiz, Marc Sagarra, Ramon Hervás, Esther Blasco, Reyes Molina, Julia Moreno, Empar F. Garcia-Curto, Eugeni J Clin Med Article (1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored. MDPI 2022-11-30 /pmc/articles/PMC9737650/ /pubmed/36498696 http://dx.doi.org/10.3390/jcm11237121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Romero-Aroca, Pedro
Baget-Bernaldiz, Marc
Sagarra, Ramon
Hervás, Esther
Blasco, Reyes
Molina, Julia
Moreno, Empar F.
Garcia-Curto, Eugeni
Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
title Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
title_full Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
title_fullStr Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
title_full_unstemmed Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
title_short Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
title_sort impact of the covid-19 pandemic on the metabolic control of diabetic patients in diabetic retinopathy and its screening
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737650/
https://www.ncbi.nlm.nih.gov/pubmed/36498696
http://dx.doi.org/10.3390/jcm11237121
work_keys_str_mv AT romeroarocapedro impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening
AT bagetbernaldizmarc impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening
AT sagarraramon impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening
AT hervasesther impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening
AT blascoreyes impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening
AT molinajulia impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening
AT morenoemparf impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening
AT garciacurtoeugeni impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening